Variations in Clinical Practice During Therapy for Pediatric Acute Lymphoblastic Leukemia

被引：0
|
作者：
Daignault, Chelsea [1 ]
Pokala, Hanumantha [1 ]
机构：
[1] Univ Oklahoma, Childrens Hosp, Oklahoma City, OK USA
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
317
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [1] Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia
    J R Roberson
    H L Spraker
    J Shelso
    Y Zhou
    H Inaba
    M L Metzger
    J E Rubnitz
    R C Ribeiro
    J T Sandlund
    S Jeha
    C-H Pui
    S C Howard
    Leukemia, 2009, 23 : 245 - 250
  • [2] Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia
    Roberson, J. R.
    Spraker, H. L.
    Shelso, J.
    Zhou, Y.
    Inaba, H.
    Metzger, M. L.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Sandlund, J. T.
    Jeha, S.
    Pui, C-H
    Howard, S. C.
    LEUKEMIA, 2009, 23 (02) : 245 - 250
  • [3] Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia
    Roberson, Jessica R.
    Raju, Sailaja
    Shelso, John
    Pui, Ching-Hon
    Howard, Scott C.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (06) : 1207 - 1212
  • [4] Severe Psychiatric Disturbances During Therapy in Pediatric Acute Lymphoblastic Leukemia
    Tsipou, H.
    Tourkantoni, N.
    Papanastasiou, L.
    Roka, K.
    Avgerinou, G.
    Katsibardi, K.
    Filippidou, M.
    Kattamis, A.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S583 - S583
  • [5] Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia
    Wolf, Joshua
    Tang, Li
    Flynn, Patricia M.
    Pui, Ching-Hon
    Gaur, Aditya H.
    Sun, Yilun
    Inaba, Hiroto
    Stewart, Tracy
    Hayden, Randall T.
    Hakim, Hana
    Jeha, Sima
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (11) : 1790 - 1798
  • [6] Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice
    Marlise R. Luskin
    Daniel J. DeAngelo
    Current Hematologic Malignancy Reports, 2017, 12 : 370 - 379
  • [7] Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice
    Luskin, Marlise R.
    DeAngelo, Daniel J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (04) : 370 - 379
  • [8] CLOFARABINE IN CLINICAL PRACTICE: THE UNITED KINGDOM EXPERIENCE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    O'Connor, D.
    Sibson, K.
    Caswell, M.
    Connor, P.
    Cummins, M.
    Mitchell, C.
    Motwani, J.
    Taj, M.
    Vora, A.
    Wynn, R.
    Kearns, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 258 - 258
  • [9] Determinants of quality of life during induction therapy in pediatric acute lymphoblastic leukemia
    Raphaële R. L. van Litsenburg
    Jaap Huisman
    Rob Pieters
    Chris Verhaak
    Gertjan J. L. Kaspers
    Reinoud J. B. J. Gemke
    Supportive Care in Cancer, 2014, 22 : 3235 - 3242
  • [10] HYPERGLYCEMIA REQUIRING INSULIN DURING INDUCTION THERAPY IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    McCormick, Meghan
    Sharp, Eleanor
    Zullo, James
    Raman, Sripriya
    Kalpatthi, Ram
    PEDIATRIC BLOOD & CANCER, 2019, 66
12345